This presentation provides a detailed overview of oculopharyngeal muscular dystrophy (OPMD), Benitec’s BB-301 gene therapy construct, as well as the associated market opportunity and product pipeline 5/15/18
Seenie from Moderator Support
Related topics
| Topic | Replies | Views | Activity | |
|---|---|---|---|---|
| Good news! | 0 | 1014 | September 13, 2017 | |
| Orphan Drug Designation from the FDA for Benitec OPMD Treatment | 6 | 1746 | June 26, 2023 | |
| OPMD worldwide MAP | 5 | 1492 | May 6, 2020 | |
| About the General category | 1 | 1680 | May 21, 2016 | |
| Link to Muscular Dystrophy Association | 2 | 1434 | April 29, 2020 |